GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kingworld Medicines Group Ltd (HKSE:01110) » Definitions » 3-Year FCF Growth Rate

Kingworld Medicines Group (HKSE:01110) 3-Year FCF Growth Rate : 0.00% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Kingworld Medicines Group 3-Year FCF Growth Rate?

Kingworld Medicines Group's Free Cash Flow per Share for the six months ended in Dec. 2023 was HK$-0.09.

During the past 12 months, Kingworld Medicines Group's average Free Cash Flow per Share Growth Rate was -168.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Kingworld Medicines Group was 53.10% per year. The lowest was -30.30% per year. And the median was 1.20% per year.


Competitive Comparison of Kingworld Medicines Group's 3-Year FCF Growth Rate

For the Pharmaceutical Retailers subindustry, Kingworld Medicines Group's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kingworld Medicines Group's 3-Year FCF Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Kingworld Medicines Group's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Kingworld Medicines Group's 3-Year FCF Growth Rate falls into.



Kingworld Medicines Group 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Kingworld Medicines Group  (HKSE:01110) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Kingworld Medicines Group 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Kingworld Medicines Group's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Kingworld Medicines Group (HKSE:01110) Business Description

Traded in Other Exchanges
N/A
Address
198 Daxin Road, 8th-9th Floor, Block A, Majialong Chuangxin Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518016
Kingworld Medicines Group Ltd is engaged in Distribution sales of pharmaceutical and healthcare products such as branded imported pharmaceutical and healthcare products primarily in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices primarily carried out in the PRC. It derives the majority of its revenue from Distribution sales of pharmaceutical and healthcare products segment.
Executives
Chan Lok San 2101 Beneficial owner
Zhao Li Sheng 2101 Beneficial owner
Sinopharm Capital Limited 2201 Interest of corporation controlled by you
Sinopharm Healthcare Fund L.p. 2101 Beneficial owner
Sun Hill Capital Investments Limited 2201 Interest of corporation controlled by you
Wu Aimin 2201 Interest of corporation controlled by you
Sun Hill Capital Investments Limited 2201 Interest of corporation controlled by you
Wu Aimin 2201 Interest of corporation controlled by you

Kingworld Medicines Group (HKSE:01110) Headlines

No Headlines